GlassScriptPhysician profile
Karthic Chandran
NPI 1033640222
$44,544.17
in general payments reported to CMS, 2019-2025
25 companies · $3,239 in 2025
The $3,239 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $204 · 2021: $1,968 · 2022: $2,146 · 2023: $4,430 · 2024: $33K · 2025: $3,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $25K · Food and Beverage: $7,866 · Travel and Lodging: $7,014 · Education: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,000.00 |
| Food and Beverage | $7,865.62 |
| Travel and Lodging | $7,013.62 |
| Education | $347.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,108.30 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Boston Scientific Corporation | $14,349.09 | 2021-2025 | Watchman Access System, Watchman Flx, Versacross Access Solution |
| Abbott Laboratories | $4,349.40 | 2020-2025 | Mitraclip, Perclose Prostyle, Diamondback Coronary |
| Edwards Lifesciences Corporation | $2,549.95 | 2024-2025 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| W. L. Gore & Associates, INC. | $1,138.52 | 2025 | Gore Cardioform Asd Occluder, Gore Cardioform Septal Occluder |
| Shockwave Medical, INC | $804.07 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $552.55 | 2021-2025 | Lifevest |
| Abiomed | $449.21 | 2022-2025 | |
| Cardiovascular Systems INC. | $282.81 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $276.19 | 2021-2025 | Jardiance |
| Amgen INC. | $256.89 | 2020-2024 | Repatha |
| Biotronik INC. | $216.32 | 2022-2023 | Biomonitor, Renamic Neo, Selectra |
| Cvrx, INC. | $168.10 | 2024 | Barostim Neo System |
| Baylis Medical Company INC | $154.11 | 2021 | |
| Asahi Intecc USA, INC. | $146.09 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $144.20 | 2025 | Angiovac |
| Teleflex LLC | $142.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2023 | Camzyos |
| Philips North America LLC | $115.28 | 2023 | |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| Penumbra, INC. | $48.00 | 2023 | Indigo System |
| Biosense Webster, INC. | $33.26 | 2025 | Nuvision Ice Catheter |
| Kestra Medical Technology Services, INC. | $23.50 | 2025 | Assure Wcd |
| Pfizer INC. | $20.46 | 2023 | |
| Vital Connect, INC | $18.87 | 2025 | Vitalpatch Rtm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karthic Chandran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.